|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-10-6
|
|
pubmed:abstractText |
The antimicrobial peptides human beta-defensin 1 and 2 (hBD-1 and 2) and the cathelicidin LL-37/hCAP-18 are key factors in innate immune responses of the respiratory tract. The aim of this study was to determine the concentrations of these peptides in airway surface fluid of CF patients with mild lung disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1569-1993
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
45-50
|
|
pubmed:dateRevised |
2010-9-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15463886-Adolescent,
pubmed-meshheading:15463886-Adult,
pubmed-meshheading:15463886-Antimicrobial Cationic Peptides,
pubmed-meshheading:15463886-Biological Markers,
pubmed-meshheading:15463886-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:15463886-Child,
pubmed-meshheading:15463886-Child, Preschool,
pubmed-meshheading:15463886-Cystic Fibrosis,
pubmed-meshheading:15463886-Female,
pubmed-meshheading:15463886-Humans,
pubmed-meshheading:15463886-Male,
pubmed-meshheading:15463886-Probability,
pubmed-meshheading:15463886-Prognosis,
pubmed-meshheading:15463886-Prospective Studies,
pubmed-meshheading:15463886-Risk Assessment,
pubmed-meshheading:15463886-Sensitivity and Specificity,
pubmed-meshheading:15463886-Severity of Illness Index,
pubmed-meshheading:15463886-Statistics, Nonparametric,
pubmed-meshheading:15463886-beta-Defensins
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis.
|
|
pubmed:affiliation |
Department of Pediatric Pneumology and Immunology, Charité, Humboldt-University, Berlin, Germany.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
